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ABSTRACT
Sleep problems can have a broad impact across the day-to-day functioning of an
individual. Persons with intellectual disabilities are at a particular risk for developing sleep
problems, with prevalence estimates much higher than is found in the general population.
Nonetheless, the assessment of sleep problems in persons with intellectual disabilities has been
widely overlooked. The Sleep Problems Inventory (SLEEPY) was created to measure various
factors related to sleep problems in persons with intellectual disabilities. The present study
represents the first steps in establishing the reliability and validity of the SLEEPY in adults with
intellectual disabilities.
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INTRODUCTION
Sleep has a broad effect across many of the day-to-day aspects of an individual’s life.
Because of the many areas that sleep impacts, these problems can disrupt the functioning of an
individual in many domains. Thus, sleep problems can serve to exacerbate minor difficulties or
irritations (Schreck, Mulick, & Smith, 2004). However, while sleep problems can lead to day-today difficulties and disorders, they are not necessarily the primary cause. In many instances the
sleep problem is a result of a medical condition, side effect of medication, poor sleep hygiene, or
a psychological disorder (Benca, 2000; Gillin & Drummond, 2000; Smith, Smith, Nowakowski,
& Perlis, 2003; Uhde, 2000). A large number of disorders in the DSM-IV-TR (APA, 2000)
include sleep problems among the diagnostic criteria.
Sleep problems are a common occurrence. Most people will have a sleep problem at one
point in their life, which will go away after a short duration and cause little disruption. However,
the prevalence of more significant and longstanding sleep problems is estimated between 5% and
15% (Ford & Kamerow, 1989; Mellinger, Balter, & Uhlenhuth, 1985; Ohayon, Caulet, Philip,
Guilleminault, & Priest, 1997). A significant relationship exists between sleep and psychological
functioning. Sleep disorders are often associated with emotional disorders or stressful life events
(Ford & Kamerow, 1989). Likewise, patients with chronic sleep disorders have been found to be
at an increased risk for depression, anxiety disorders, substance abuse disorders, and nicotine
dependence (Breslau, Roth, Rosenthal, & Andreski, P., 1996; Ford & Kamerow, 1989).
Improvements in mood may often be found when treating the underlying sleep problem (Jacobs,
Benson, & Friedman, 1993; Jacobs, Pace-Schott, Stickgold, & Otto, 2004). Because of the
diverse areas that sleep impacts, an increased knowledge of the assessment and treatment of
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sleep problems has significant potential to aid a myriad of health professionals in assisting their
clients.
In an effort to increase the clinician’s ability to identify and diagnose sleep disorders, a
number of assessment methods have been developed, including polysomnography, actigraphy,
and questionnaires. Two of the most frequently used questionnaires are the Epsworth Sleepiness
Scale (Johns, 1991) and the Stanford Sleepiness Scale (Hoddes, Dement, & Zarcone, 1972). The
efforts to develop more reliable and valid assessment measures have for the most part been
successful and have shown adequate psychometric properties (Herscovitch & Broughton, 1981;
Johns, 1994). Nonetheless, the assessment of sleep problems in persons with intellectual
disabilities has been widely overlooked. Few measures have been constructed to assess for sleep
disorders in adults with intellectual disabilities and only one measure, the Behavior Evaluation of
Disorders of Sleep (BEDS; Schreck, 1997/1998), has been constructed to assess for sleep
disorders in children with intellectual disabilities. A questionnaire by Simonds and Parraga
(1984) has been used in modified forms across a number of studies in persons with intellectual
disabilities (e.g. Brylewski & Wiggs, 1999; Didden, Korzilius, van Aperlo, van Overloop & de
Vries, 2002; Wiggs & Stores, 1996). However, only one study addressed the psychometric
properties of this questionnaire (Hunt & Stores, 1994). One other tool that has been developed to
assess for sleep problems in persons with developmental disabilities is the Diagnostic
Assessment for the Severely Handicapped (DASH-II; Matson, 1993). The DASH-II is an
informant based screening tool for the rapid assessment of psychopathology in persons with
developmental disabilities. The DASH-II contains a sleep disorders subscale consisting of 5
items. Initial evaluation of the psychometric properties of the sleep subscale are favorable.
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However, in line with the overall purpose of screening for a broad spectrum of psychopathology,
the item content of the DASH-II sleep scale is limited.
The paucity of assessment measures for sleep disorders in persons with intellectual
disabilities is most striking when considering the prevalence of reported sleep problems in this
population, which are estimated at 23% to 51% (Bartlett, Roney, & Spedding, 1985; Quine,
1991). Johnson (1996) notes that the relative lack of research on sleep disorders in persons with
intellectual disabilities may be due partially to a lack of valid and reliable assessment measures
designed for use in this population. However, whatever the reason, there is no debate about the
fact that little attention has been paid to sleep irregularities as applied especially to persons with
severe and profound mental retardation.
The present study represents the first step in establishing a measure to assess for sleep
problems in adults with intellectual disabilities. While the sleep subscale of the DASH-II may be
useful to identify potential problems with sleep as a part of a larger evaluation, a more in depth
assessment of sleep problems containing a broader content (e.g., breathing related sleep
problems) would do much to advance research and treatment of sleep problems in persons with
developmental disabilities. The Sleep Problems Inventory (SLEEPY) was created to measure
various factors related to sleep disorders in persons with intellectual disabilities, a little explored
area. An important first step in establishing acceptable psychometric properties of this measure is
examining the SLEEPY’s factor structure, reliability, and validity.
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REVIEW OF LITERATURE
Sleep Disorders
Assessment of Sleep
Sleep has been a topic of philosophical musing since early history. However, it was only
in the last century that the study of sleep emerged as a serious scientific endeavor (Dement,
2000). The advent of sleep as a topic of scientific inquiry can be dated to 1930, when Hans
Berger demonstrated that the sleeping brain produced electrical rhythms that were distinct from
the rhythms produced while awake (Berger, 1930). Berger titled the electrical recordings
“electroencephalograms” (EEG), and thus a method to measure and study activity in the sleeping
brain emerged. The sophistication of EEG methods has improved dramatically since its inception
and it still remains a major component of polysomnography (PSG), the gold standard for
establishing the presence of a sleep disorder (Smith, Nowakowski, Soeffing, Orff, & Perlis,
2003). There are primarily four ways that sleep is assessed. They include PSG, actigraphy, direct
observation, and self-report (questionnaires, sleep diaries, etc.).
When used for measuring sleep, PSG consists of three measures, EEG, electromyography
(EMG), and electrooculography (EOG) (Smith, et al., 2003). All three measures are indices of
electrical activity produced by their respective locations (scalp, muscles, and eyes). While EEG
is the primary measure, EMG and EOG are useful in determining sleep stage (such as REM
sleep). When combined with other measures of cardiac, respiratory, and peripheral nervous
system activity, the PSG becomes a very sensitive tool for diagnosing various dyssomnias and
parasomnias (Smith et al., 2003). However, PSG is cumbersome and is almost exclusively
conducted in a laboratory environment, yet technology continues to improve as new
advancements have been integrated into the process. Efforts to develop portable and less
intrusive devices for PSG have begun to receive the attention of researchers (Chervin, 2000);
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however, entirely different ways of measuring sleep such as actigraphy have also been developed
as a means to overcome the cumbersomeness of PSG.
Actigraphy is a useful but often underused measure of sleep (Ancoli-Israel, Cole, Alessi,
Chambers, Moorcroft, & Pollak, 2003; Smith, et al., 2003). Simply put, actigraphy is a
measurement of activity summated over a number of time intervals. It is assumed that although
movement may occur while sleeping or the individual may be inactive while awake, that overall,
activity indicates wakefulness and inactivity indicates sleep. In studies with humans, the
actigraph is usually worn on the wrist, similar to a wristwatch. One benefit of the actigraph over
PSG is its portability. While early models have been somewhat obtrusive, newer models are
smaller and may be disguised in the shape of a wristwatch to decrease the awkwardness of
wearing the device in day-to-day circumstances. In a critical review of the methodological issues
with actigraphy, Tryon (2004) concluded that while studies have found that PSG and actigraphy
do not relate well, this variability is not random, but systematic and controllable. Further, Tryon
(2004) points out that the reliability coefficients meet or exceed those of commonly used medical
or psychological tests. Ancoli-Israel et al. (2003) concluded that actigraphy is a moderately valid
and reliable means to differentiate sleep states but becomes less reliable as the severity of sleep
problems increase. Further, Ancoli-Israel et al. (2003) commented that while actigraphy is less
reliable, it can be used in situations where PSG is not practical. Nonetheless, there remains much
that still needs to be done to validate the use of actigraphy to measure sleep problems.
Direct observations are commonly used in residential and inpatient settings. This
procedure consists of monitoring an individual for the presence of sleep over a series of intervals.
Observable definitions of sleep must be clearly stated as well as the rate of intervals. For the data
to show meaningful changes, the intervals should be 30 minutes or less. However, Smith et al.
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(2003) point out that as the time between intervals decreases, the compliance and vigilance of
direct care staff to reliably observe the individual may decrease. Further, error may be introduced
by poorly defined target behaviors. Nonetheless, this procedure is inexpensive and easy to
implement. Moreover, adequate training as well as explicit behavioral definitions of the target
behaviors may control much of the unreliability.
Self-report measures are a mainstay of clinical sleep assessment (Smith et al., 2003).
These assessments may vary from informal questions about sleep quality to validated scales.
While commonly used, self-report measures have a number of problems with validity that
depend upon the particular aspects of the measure used. For instance, retrospective measures and
prospective measures like sleep logs depend upon the ability of the individual to report
accurately (Smith et al., 2003). A number of factors may influence the individual’s recall on such
scales including primacy, recency, and confirmation bias. Further, they depend upon how well
the individual can average their sleeping behavior across a number of days and report on their
“overall” sleep. Prospective measures such as sleep diaries are not as dependent upon an
individual’s long-term memory or the ability to summate their sleep. However, sleep diaries
commonly ask the individual to rate things such as how long it took them to fall asleep. Whether
an individual can answer such items accurately is questionable (Smith et al., 2003). While these
limitations are significant, self-report measures still provide useful and valid information if
constructed properly and used in the appropriate context (Smith et al., 2003).
The methods used to assess for particular sleep disorders is highly dependent upon the
disorder in question. For example, the diagnostic tools to evaluate for insomnia will differ greatly
from those used in obstructive sleep apnea. PSG may continue to be the gold standard for
diagnosing a sleep disorder (Ancoli-Israel et al., 2003). However, this method requires
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substantial amounts of time and resources. Many sleep disorders may be identified by more
efficient means such as structured interviews and questionnaires. When available, other methods
that are more cost effective, less intrusive, and more adaptable to measuring sleep in the natural
setting may be preferred.
Classification of Sleep Disorders
The classification of sleep disorders has received a good deal of attention. The two most
frequently used classification systems are the International Classification of Sleep Disorders
(ICSD) and the DSM-IV-TR. The ICSD, originally published in 1990 by the American Sleep
Disorder Association was revised in 2000 with the purpose of updating the ICSD code numbers
to match the ICD-10 system. The ICSD was published primarily with the goal of expediting
diagnosis and classification for epidemiological purposes. In spite of the similarities between the
ICSD and the DSM-IV, there has been much debate over which system ought to be used.
Because of the greater number of subdivisions and categories in the ICSD, many sleepspecialists prefer this nosology (Thorpy, 2000). However, while useful for diagnosis or
epidemiological information, this degree of subdivision is not usually found in the research
literature. Instead, more general terms are often employed.
In the ICSD system, the disorders are broken down into four categories: (1) dyssomnias;
(2) parasomnias; (3) sleep disorders associated with mental, neurologic, or other medical
disorders; and (4) proposed sleep disorders, disorders with insufficient data to show clear
diagnostic guidelines (American Academy of Sleep Medicine, 2000). The ICSD results in 84
distinguishable sleep disorders.
The DSM-IV-TR categories include: (1) Primary Sleep Disorders, which is broken down
into dyssomnias and parasomnias; (2) sleep disorders related to another mental disorder; (3)
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sleep disorders due to a general medical condition; and (4) substance-induced sleep disorder.
While the two classification systems are divided differently, many of the same disorders are
included in both, but are simply classified into different sections. While developers of both
systems attempt to organize the disorders based upon known etiology, they have arrived at
different outcomes. This development may be due in part to efforts to match the ICSD’s coding
system to that of the ICD.
Regardless of classification system, historically, sleep disorders not due to a substance or
medical condition are separated into two categories: dyssomnias and parasomnias. The
dyssomnias consist of problems related directly to the sleep process (i.e. amount, quality, and
timing of sleep). The parasomnias consist of problems that occur during sleep or sleep-wake
transitions. According to the DSM-IV-TR (APA, 2000) the dyssomnias include Primary
Insomnia, Primary Hypersomnia, Narcolepsy, Breathing-Related Sleep Disorder, Circadian
Rhythm Sleep Disorder, and Dyssomnia Not Otherwise Specified. The parasomnias include
Nightmare Disorder, Sleep Terror Disorder, Sleepwalking Disorder, and Parasomnia Not
Otherwise Specified. A detailed discussion of each sleep disorder is beyond the scope of this
paper, particularly in light of the high differentiation in the ICSD; however, they will be covered
generally, with emphasis on the disorders recognized by both the DSM-IV-TR and ICSD.
Dyssomnias
Insomnia
Insomnia is one of the most common sleep disorders. Depending on the definition used,
prevalence estimates vary from 10-50% (Zorick & Walsh, 2000). Most conservative estimates
fall around 10% in a six month time period (Ford & Kamerow, 1989; Simon & VonKorff, 1997).
In persons between 20 and 40 years of age, prevalence estimates do not vary by gender.
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However, in persons over 65 years of age, women are more likely to have problems with
insomnia than men (Zorick & Walsh, 2000). Further, persons over 65 are in general more likely
to experience problems with insomnia than younger adults (Ganguli, Reynolds, & Gilby, 1996).
Children and adolescents are also more susceptible to having problems with insomnia, with
children 6-24 months old having prevalence rates of 20-30% (Lozoff, Wolf, Davis, 1985;
Richman, 1981). From the ages of 4-8 these rates decrease to approximately 15% (Zorick &
Walsh, 2000). These data suggest that prevalence rates of insomnia follow a developmental
course in which persons in early childhood and older adulthood are more likely to experience
this problem.
A number of environmental, psychological, and medical factors may cause or lead to
insomnia. Factors rarely occur singularly; rather, they occur in concert with one another. For
example, Parkinson’s disease may cause insomnia (Garcia-Borreguero, Larrosa, & Bravo, 2003).
However, individuals dealing with this medical condition also often experience anxiety and
depression, both of which are known to contribute to problems with insomnia. For diagnostic and
treatment purposes, teasing apart the various factors contributing to the insomnia is complex and
difficult.
For cases in which insomnia occurs in the absence of psychological, environmental, and
medical problems, the insomnia is considered to be free-standing and thus is seen as a root
problem rather than a symptom of another disorder (Hauri, 2000). The DSM-IV-TR classifies
these cases as Primary Insomnia. The ICSD has three classifications for free-standing insomnia:
psychophysiological insomnia, sleep-state misperception, and idiopathic insomnia.
Compelling evidence is available to suggest that primary insomnia is fundamentally
different from other forms of insomnia in which sleep deprivation is imposed on the individual
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as a result of some other disorder. The most significant difference is that persons with primary
insomnia appear to be hyperaroused (Hauri, 2000). Likewise, Bonnet and Arand (1995) have
shown that persons with insomnia more closely resemble hyperarousal than sleep deprivation.
Because of the many different causes for insomnia, the assessment process must be
broad. Insomnia is most commonly diagnosed by history alone (American Sleep Disorder
Association, 1995; Chervin, 2000; Reite, Buysse, Reynolds, & Mendelson, 1996). PSG,
actigraphy, self report, and direct observations may also all be employed to determine the
severity of the insomnia even though not necessary to determine the actual presence of the
disorder (Chervin, 2000). The diagnostic process becomes more complicated though when
attempting to determine the etiology of the insomnia. In doing so, many other domains need to
be assessed, including both psychiatric and medical causes. PSG is useful to assess for physical
abnormalities such as BRSD. However, the cause may often simply be inadequate sleep hygiene.
Chervin (2000) points out that PSG should not be overused as it may convince the patient that
the cause of the insomnia is biological and undermine attempts to effectively treat the insomnia
behaviorally.
Insomnia is troublesome and frustrating for many people who experience it frequently.
However, it is not particularly the inability to fall asleep that is found distressing, but rather it is
the consequences of getting too little sleep that are seen as the problem. Lack of sleep can
increase irritability, lead to excessive daytime sleepiness, or impair functioning while at work
(Zorick & Walsh, 2000). However, these symptoms may be caused by any sleep disorder that
impairs the amount, quality, or timing of sleep.
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Hypersomnia
Sleep is often considered a drive state, in much the same way as hunger. As time without
food increases, hunger also increases and is reduced by food consumption; likewise sleepiness is
also increased by time without sleep and is reduced by sleeping. However, sleep is not simply a
singular process of deactivation due to sleep-debt, but rather consists of multiple processes.
Borbély (1982) originally proposed a two-factor model in which the drive for sleep consists of
homeostatic and circadian-rhythm components. This model has received much support and is
still widely held (Cluydts, Valck, Verstraeten, & Theys, 2002). Other models have been
proposed by various researchers, which include three or more factors (Folkard & Åkerstedt,
1987). However, systems of sleepiness that rely solely upon systems of deactivation may not
capture the whole picture. A system of two opposing processes controlling the sleep-wake state
was proposed by Edgar, Dement, and Fuller (1993) in which a drive for sleep consisting of sleepdebt and deactivating chronobiological factors compete with a drive for wakefulness consisting
of environmental and activating chronobiological factors. Such a system of various processes
competing to both activate and deactivate is more in line with the heterogeneity of problems with
sleep.
For most people, sleepiness will wax and wane throughout the day with a decrease in
alertness during the mid-afternoon (2:00 pm) and more severely during early morning (2:00 am)
(Mitler & Miller, 1996). The drop in alertness during the afternoon corresponds to a peak in body
temperature and the drop in the late evening corresponds with a significant drop in body
temperature. However, these temperature peaks and drops may vary as there is much
heterogeneity among individuals (Cluydts et al., 2002). Excessive daytime sleepiness is a
common complaint. As excessive daytime sleepiness becomes more severe it may lead to mild
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problems such as inattentiveness or to more serious problems such as motor vehicle accidents.
Mild cases of excessive daytime sleepiness may simply be due to poor sleep hygiene. However,
more severe cases of excessive daytime sleepiness are frequently associated with obstructive and
central sleep apnea, restless leg syndrome, and neurodegenerative diseases (El-Ad & Korczyn,
1998).
Idiopathic hypersomnia (ICSD) or primary hypersomnia (DSM-IV) consists of
complaints of severe excessive daytime sleepiness in the presence of normal sleep architecture.
The diagnosis of idiopathic/primary hypersomnia depends greatly upon the process of ruling out
other sleep disorders such as narcolepsy or obstructive sleep apnea. Much of the diagnosis of
hypersomnia relies upon self-reported problems with daytime somnolence. The gold standard for
measuring daytime sleepiness is the multiple sleep latency test (MSLT; Mitler, Carskadon, &
Hirshkowitz, 2000). The MSLT consists of a series of naps while undergoing PSG to determine
how quickly the individual is able to fall asleep. The time until sleep onset is computed as an
index of the individual’s sleepiness. While self-report has not been found to correlate well with
MSLT (Chervin, Aldrich, Pickett, & Guilleminault, 1997), measures such as the Stanford
Sleepiness Scale (Hoddes, et al., 1972) and the Epworth Sleepiness Scale (Johns, 1991) may
provide more reliable results.
Narcolepsy is essentially defined the same by both the ICSD and DSM-IV-TR. The
DSM-IV diagnostic criteria include irresistible attacks of refreshing sleep that occur daily over at
least 3 months and the presence of cataplexy or intrusions of REM sleep during sleep-wake
transitions (APA, 2000). Recognition of the disorder dates back to 1880 when Gelineau first
coined the term narcolepsy and described it as short episodes of irresistible sleep that were
sometimes preceded by falls (Guilleminault & Anagnos, 2000). The disorder was further refined
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in 1934 by Daniels who developed the cluster of symptoms commonly known as the “narcoleptic
tetrad.” These five symptoms consisted of daytime sleepiness, cataplexy, sleep paralysis, and
hypnagogic hallucinations. While substantial progress has been made concerning the etiology of
the disorder, one can see from the current ICSD and DSM definitions that not much has changed
concerning the disorder’s clinical features.
Onset of narcolepsy is most likely to occur in the mid 20’s with approximately 50% of
the known cases being preceded by an abrupt change in the sleep pattern or a severe
psychological stressor (Guilleminault & Anagnos, 2000). The prevalence of narcolepsy has been
estimated at .02-.06% (Hublin, Partinen, Kaprio, Koskenvuo, & Guilleminault, 1994; Mignot,
1998). However, due to the genetic components of the disorder, prevalence rates may vary
significantly by region. A large body of research has been conducted concerning the genetic
transmission of narcolepsy. It is reasonable to conclude that there is a strong genetic basis to the
disorder (Guilleminault & Anagnos, 2000). Juji, Satake, Honda, and Doi (1984) found that 85%
of their sample of persons with definite cataplexy shared a common human leukocyte antigen
(HLA) allele on chromosome 6. However, Guilleminault, Mignot, and Grumet (1989) showed
that this same genetic marker is also found in 12-38% of the general population. Thus, it is likely
that the development of narcolepsy is the possible result of a specific genetic vulnerability
combining with environmental and psychological stressors.
A large portion of the process of diagnosing sleep disorders consists of ruling out other
causes. Because of the similarity of presentation of symptoms among these disorders, this
process may be quite lengthy. Disorders of hypersomnia such as idiopathic hypersomnia or
narcolepsy may impair a number of areas related to daytime functioning and sleep. However, as
with insomnia, these symptoms are not exclusively due to hypersomnia but may be caused by
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other disorders of sleep such as sleep apnea. When evaluating for possible causes of
hypersomnia, breathing related sleep disorder (BRSD) should also be considered.
Breathing-Related Sleep Disorder
BRSD can consist of apneas (breathing cessation), hypopneas (slow or shallow
breathing), and hypoventilation (low oxygen blood levels). Three forms of BRSD are recognized
in the DSM-IV-TR: obstructive, central, and central alveolar hypoventilation. In obstructive
sleep disorder the central nervous systems regulation of sleep breathing is maintained although
breathing is inhibited, usually due to some physical obstruction of the upper airway (Ayappa &
Rapoport, 2003). This form of BRSD is the most common and occurs more frequently in
overweight individuals. Characteristics of obstructive sleep disorder include loud snores and
brief gasps with alternating silence. Snoring can be quite loud and can significantly disrupt the
sleep of bed partners or other persons living in the home.
Central BRSD consists of cessation of sleep breathing without obstruction of breathing
passages. Central BRSD is usually the result of a cardiac or neurological condition. Because of
its presentation, central BRSD is much less noticeable than obstructive BRSD. In alveolar
hypoventilation, low blood oxygen levels and high carbon dioxide levels are present in spite of
normal lung mechanics. Shallow or slow breathing may be the cause. As with obstructive sleep
apnea, obesity is a prime cause.
There are a number of recognized risk factors for developing BRSD, the most frequently
noted include high body mass, craniofacial malformations, and male gender (Jordan & McEvoy,
2003; Redline & Tishler, 2000). The discrepancy in prevalence between males and females may
be due in part to the differing distribution of fat throughout the body between males and females.
In a study evaluating gender differences in sleep disordered breathing, Young (1993) found that
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gender differences were eliminated when waist-hip ratio and neck girth were analyzed instead of
their body mass index (BMI). However, there is some evidence that female sex hormones may
serve a protective role against developing BRSD (Jordan & McEvoy, 2003). Likewise, women
appear to have shorter soft-palates, which reduces the potential for collapse of the upper airway
during sleep, causing obstruction (Jordan & McEvoy, 2003).
The value of clinical impressions in the diagnosis of BRSD is questionable, showing poor
sensitivity and specificity (Hoffstein & Szalai, 1993; Viner, Szalai, & Hoffstein, 1991).
Considering the high correlation of BRSD with various physical features of the individual,
Kushida, Efron, and Guilleminault (1997) developed a predictive model of obstructive sleep
apnea. Their model, which is based upon BMI, neck circumference, and various craniofacial
measurements, was used to correctly classify 98% of individuals with obstructive sleep apnea.
While their model is an improvement over simple clinical impressions or history taking, PSG
remains the most common method of assessment of BRSD and is considered the gold standard
(Chervin, 2000). Because of the cost and intrusiveness of PSG in laboratory settings, efforts have
been made to develop portable recording devices. However, not much data have been collected
concerning the reliability of these devices in regards to laboratory PSG (Chervin, 2000).
Circadian Rhythm Sleep Disorder
The synchronization of internal processes such as sleep-wake cycles with the external
environment depends upon how well the circadian clock is in tune with the world around us
(Baker & Zee, 2000). A number of naturally occurring cues are used to reset or realign the
timing of our internal clock with the external environment. These cues are known as zeitgeibers,
or “time-givers”. Of the known zeitgebers, light has the strongest effect (Avissar, et al., 1999;
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Wirz-Justice, 1998). Many other zeitgebers have been identified such as food consumption,
temperature, social cues, and physical activity.
By a series of ablation studies in rats, Richter (1967) found that only lesions of the
hypothalamus resulted in a loss of circadian rhythm. Because of the known role that light plays
in regulating circadian rhythms, it was hypothesized that by tracing projections from the optic
nerve, the specific area concerned with regulating circadian rhythms could be identified (Moore
& Eichler, 1972). Indeed, such a projection was found to lead to the suprachiasmatic nucleus
(SCN; Moore & Eichler, 1972). Various ablation studies have confirmed the SCN’s role in
synchronizing sleep with the external environment (Moore & Lenn, 1972; Stephen & Zucker,
1972). However, the specific mechanism by which it does so remains unknown (Harrington &
Mistlberger, 2000). Further, a number of other regions such as the pineal gland have been
implicated in the process of circadian regulation.
A malleable system of sleep regulation is needed due to naturally occurring variations in
the environment such as seasonal changes. Unnatural variations such as late-shift work and
traveling through time zones also requires a system that is malleable and able to be reset.
However, these unnatural variations may be too severe and sleep problems may arise when the
synchronization of internal cycles with external cycles is lost. Desynchronization, or phase shifts,
may occur for multiple reasons, which are commonly classified into two categories: (1) the
environmental light/dark cycles changes relative to the individual’s internal clock (shift work or
time-zone travel) or (2) the individual’s internal clock changes relative to stable environmental
cycles (Baker & Zee, 2000).
The essential problem with circadian rhythm sleep disorder is that the individual is
unable to sleep when it is desired or socially expected. In circadian rhythm sleep disorder, the
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actual process of sleep remains unimpaired, however, the timing of sleep is mismatched with the
environment. As with many sleep disorders, the presenting complaint is often insomnia or
excessive daytime drowsiness. However, in circadian rhythm sleep disorder further investigation
will show that the problem is not necessarily with falling asleep, but rather the timing of sleep
onset. As with most sleep disorders, PSG is the gold standard for the diagnosis. Actigraphy and
self-report of problems are also helpful in determining the specific characteristics of the disorder.
Parasomnias
Non-REM Parasomnias
Sleep-walking, sleep terrors, and confusional arousal are typically grouped together
because they almost exclusively occur during NREM sleep, have similar genetic patterns, and
are more common in children (Broughton, 2000). Indeed, the ICSD recognizes this grouping as a
category, however the DSM-IV-TR does not categorize them but simply lists each as an
individual parasomnia. These disorders also occasionally overlap with one another with aspects
of confusional arousal being present in both sleep terrors and sleep-walking (Broughton, 2000).
As may be implied by its title, confusional arousal consists of periods of confusion after
arousal from sleep, most commonly during slow wave sleep. While the ICSD recognizes this
particular disorder, the DSM-IV-TR does not provide a specific diagnostic code. Little has been
done concerning epidemiological studies of confusional arousal. Likewise, little is known
concerning the pathophysiology. However, factors that may deepen sleep such as youth,
medication, or sleep deprivation may increase the frequency of occurrence (Broughton, 2000).
Confusional arousal usually does not impair the individual as long as objects are not left near the
bed such as water glasses that may be broken and cause injury.
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Sleep terrors consist of abrupt awakenings from sleep with loud screams or crying as well
as autonomic arousal and feelings of intense fear. Both the ICSD and DSM-IV-TR recognize
sleep terrors as a disorder. Sleep terrors occur primarily in children, with one to six percent
experiencing the disorder (Broughton, 2000; Kales, Kales, Soldatos, Caldwell, Charney, &
Martin, 1980). The condition is found far less frequently in adults with less than one percent
experiencing the disorder. There appears to be a strong genetic component to sleep terrors
(Kales, Soldatos, Bixler, Ladda, Charney, Weber, & Schweitzer, 1980). However, the
pathophysiology remains unknown (Broughton, 2000). As with confusional arousal, while
unpleasant and distressing, sleep terrors rarely cause injury nor serve as signs of other more
serious disorders.
According to the ICSD, sleep-walking consists of the individual arising from a deep
sleep, usually slow wave sleep, and engaging in a series of complex behaviors, resulting in
getting out of bed and walking. In spite of previously held notions that sleepwalking was a
significant sign of other pathology, it usually causes minimal harm and will resolve itself if
allowed to “run itself out” (Broughton, 2000). Sleepwalking is common in children with three to
four percent having frequent sleepwalking episodes (Kales, Soldatos, Caldwell, Kales,
Humphrey, Charney, & Schweitzer, 1980). As with sleep terrors, there appears to be a genetic
component, with roughly 80% of sleepwalkers having a significant family history (Kales,
Soldatos, Caldwell, et al, 1980).
REM Parasomnias
REM sleep behavior disorder (RBD) and nightmares are the two most commonly
researched REM sleep disorders. Nightmares are a common occurrence for most individuals and
lifetime prevalence may be assumed to approach 100% (Nielsen & Zadra, 2000). While some
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debate continues over what constitutes a nightmare, it is commonly held that nightmares are
frightening dreams that awaken the individual. Nightmares are more common in children and
decrease with age. However, it is not uncommon for nightmares to occur in adulthood, with
estimates ranging from 8-25% (Nielsen & Zadra, 2000).
REM sleep behavior disorder (RBD) consists of the loss of atonia associated with REM
sleep and excessive motor movements related to dream content. In RBD, injury may occur to the
individual or bed partner as often the movements reflect punching or kicking motions. The atonia
seen during REM sleep is primarily the result of inhibition of motor activity by the pontine
centers of the peri-locus ceruleus, which in turn causes the medulla to hyperpolarize the motor
neurons of the reticulospinal tract (Mahowald & Schenck, 2000). As the central nervous system
develops during infancy, the REM atonia becomes more stable and movement during REM sleep
decreases. Any impairment in the structures regulating the inhibition of motor activity may result
in RBD. Chronic cases are usually related to neuromaldevelopment or neurological damage.
Acute problems of RBD have been observed in persons taking excessive amounts of caffeine,
tricyclic antidepressants, monoamine oxidase inhibitors, and various antipsychotics (Mahowald
& Schenck, 2000). Because of the association with Parkinson’s disease and dementia,
individuals with chronic cases should be evaluated by a neurologist to rule out these disorders.
Sleep Bruxism
Sleep Bruxism (SB) is defined by the ICSD as a stereotyped movement disorder
characterized by grinding or clenching of the teeth during sleep. The disorder is differentiated
from daytime clenching and grinding of teeth in that it takes place while sleeping and thus is
believed to not be under volitional control. There is evidence to suggest a psychological
component in that SB increases following stressful days or in anticipation of stress (Funch &
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Gale,1980; Rugh & Solberg, 1975). SB can lead to severe wearing away of the teeth as well as
damage to the bone and muscles of the jaw. This problem may result in significant tooth and jaw
pain, as well as temporal area headaches. SB does not usually occur every time the individual
sleeps but rather has a good deal of fluctuation (Lavigne & Manzini, 2000). SB is usually not
noticed unless the individual’s bed partner is disturbed by the grinding noises or the individual’s
dentist observes the tooth wear (Lavigne & Manzini, 2000). While SB is usually the primary
diagnosis, it may occur secondary to a medical condition. For example, withdrawal from
neuroleptics or neuroleptic induced dyskinisia may cause non-volitional jaw movements that
persist during sleep. In such a case, the SB would be secondary to the dyskinisia (Micheli,
Pardal, Gatto, Asconapé, Giannaula, & Parera, 1993; Bassett, Remick, Blasberg, 1986). Due to
the inherent difficulty in observing SB and the individual’s frequent lack of awareness of the
occurrence of SB, prevalence estimates are preliminary. Estimates of frequent SB in the general
population range from 5-20% (Glaros & Rao, 1977). However, infrequent teeth grinding during
sleep is fairly common, occurring in 85-90% of the population (Bader & Lavigne, 2000). It is
only when the SB causes severe tooth wear or disturbs the sleep of the individual or their bed
partner that it becomes clinically significant.
The etiology of sleep problems is diverse. Many disorders of sleep may result in similar
symptoms. Various mental disorders or medical conditions may also lead to sleep problems.
Because these various factors work in concert with one another, a thorough evaluation must also
consider the role that mental disorders or medical conditions may play in sleep disturbances.
Mental Disorder or Medical Condition
Sleep disorders due to another mental disorder or medical condition are often not
diagnosed or are simply overlooked. The diagnosis of these sleep disorders is often difficult due
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to the inclusion of sleep disturbance as a criteria for other mental disorders such as Major
Depressive Disorder or Generalized Anxiety Disorder. However, even when due to another
disorder, the sleep disturbance may become of such a magnitude that it takes on a life of its own
and warrants a second diagnosis. For the diagnosis of sleep disorders related to another mental
disorder or medical condition, the ICSD provides much more definitive categories than the
DSM-IV-TR, which simply calls for the clinician to specify which disorder is the primary cause
of the sleep disturbance. The ICSD list of mental disorders includes psychosis, mood disorders,
anxiety disorders, panic disorders, and alcoholism. The ICSD list of neurologic disorders
includes cerebral degenerative disorder, dementia, parkinsonism, fatal familial insomnia, sleeprelated epilepsy, electrical status epilepticus of sleep, and sleep-related headaches. The list of
other medical disorders includes: sleeping sickness, nocturnal cardiac ischemia, chronic
obstructive pulmonary disease, sleep-related asthma, sleep-related gastroesophageal reflux,
peptic ulcer disease, and fibromyalgia. With its specific categories, the ICSD system is more
readily adapted to compiling epidemiological and statistical information.
As can be seen from the long list of mental and medical disorders that the ICSD includes,
sleep disturbances may arise from disparate sources. No one particular health professional will
receive all referrals that may be related to a sleep disorder. Physicians, psychologists,
psychiatrists, neurologists, and nurses all need to be aware of the impact that sleep problems may
have on the disorders that define their specialty. A brief review will be provided of those
disorders that are the most commonly reported in persons with intellectual disabilities. These
conditions include depression, anxiety, and epilepsy.
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Anxiety and Depression
When discussing sleep disorders in the context of anxiety and depression, much of the
research becomes blurred. This problem is due in part to the overlap of disorders and sleep
problems that are often conceptualized as symptoms of depression and anxiety (Ware & Morin,
1997). Further, considering the high prevalence of anxiety and mood disorders across the
lifespan, little research has been done concerning their impact on sleep or vice-versa (Uhde,
2000). Nonetheless, the available research does indicate a significant relationship between sleep
and these disorders (Benca, 2000; Uhde, 2000).
Relaxing before bedtime is a significant step in settling before sleep onset. However,
many individuals with anxiety disorders report worrying and thinking about problems after
laying down to sleep (Uhde, 2000). This situation may pose a significant problem to the process
of winding-down (Spielman, Conroy, & Glovinsky, 2003). Indeed, 50% to 70% of persons with
generalized anxiety disorder report problems with sleep and 30% report moderate to severe
problems (Anderson, Noyes, & Crowe, 1984; Uhde, Tancer, & Gurguis, 1990). Additionally,
intrusive thoughts and ruminations have been shown to disrupt sleep in person with obsessive
compulsive disorder, with these individuals showing fragmented and restless sleep (Insel, Gillin,
Moore, Mendelson, Loewenstein, & Murphy, 1982; Uhde, 2000). Post-traumatic stress disorder
(PTSD) poses a particular problem to sleep, particularly in having trouble initiating sleep or with
recurrent nightmares. Further, the individual with PTSD may develop a conditioned fear to sleep
if the trauma occurred while they were sleeping, such as a house-fire or burglary (Uhde, 2000).
Since sleep problems are a diagnostic criteria for mood disorders, the high association of
insomnia and depression should not be surprising. Mellinger, Balter, and Uhlenhuth (1985)
found that persons with serious insomnia complaints were much more likely (three times more
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likely) to report depression than those with only minor complaints of insomnia. While
conventional wisdom holds that depression causes impairment in sleeping, there is increasing
evidence that impaired sleep may also cause depression. For example, Ford and Kamerow (1989)
found that individuals whose sleep disturbances persisted between baseline assessment and a 1year follow-up were much more likely to have developed a new major depressive disorder. A
similar study (Breslau et al.,1996), which did not include sleep disturbances as a criteria for
depression, also found that sleep disturbances were a significant risk for developing a depressive
disorder. Similarly, treating sleep disturbances have been shown to be effective in reducing
anxiety and depression (Jacobs et al., 1993)
A number of theories have been proposed to account for the role that sleep plays in
anxiety and depression. These theories consider REM suppression, cholinergic-aminergic
imbalance in REM sleep regulation and problems with the circadian regulation of sleep/wake
cycles. While no one theory is able to explain the various symptoms, sleep and anxiety and sleep
and depression appear to be significantly linked (Benca, 2000). Examining these links may lead
to more effective treatments for sleep disorders as well as for depressive and anxiety disorders.
Epilepsy
Many individuals who experience nocturnal seizures are not aware of the seizure activity
at all, but rather present with complaints of sleep fragmentation, poor sleep quality, and daytime
tiredness (Provini, Plazzi, Montagna, & Lugaresi, 2000). Many nocturnal seizure disorders will
remit without treatment; this is particularly the case in children (Pressman, Gollomp, Benz, &
Peterson, 1997). Seizure activity and sleep disorders appear to be significantly related to one
another. Sleep deprivation has been shown to increase seizure activity (Shouse & Mahowald,
2000). However, seizures may also increase the incidence of sleep disorders. To further
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complicate the picture, anticonvulsants have a significant impact on REM sleep, and epileptic
discharges have been known to exacerbate periodic limb movements (Pressman et al., 1997).
Some parasomnias such as arousal disorders are often misdiagnosed as nocturnal
seizures. Indeed, there is a good deal of overlap between sleep and epileptic phenomena
(Eisenman, & Attarian, 2003). For example, normal occurrences in sleep such as hypnic jerks,
which involve motor, visual, auditory, or somethetic sleep starts may be confused as seizure
activity (Shouse & Mahowald, 2000). However, these events may also be the only manifestation
of a seizure disorder (Fornazzari, Farcnik, Smith, Heasman, & Ichise, 1992). Additionally,
disorders of arousal such as REM sleep behavior disorder, nightmares, periodic limb movement
disorder, nocturnal panic attacks, and enuresis may have significant overlap with seizure
disorders. Differential diagnosis is extremely difficult. Standard practices to assess for seizures
such as EEG recordings may be obscured by normal sleep phenomena. In light of the
complicated diagnostic picture and the common comorbidity of sleep and seizure disorders, an
awareness of both sleep and seizure disorder manifestations is necessary (Shouse & Mahowald,
2000). The clinician needs to be vigilant in exploring both possibilities, especially in such cases
where the phenomena may lead to injury.
Sleep Disorders in Persons with Intellectual Disabilities
Prevalence and Classification Issues
The prevalence of sleep problems in persons with intellectual disabilities appears to be
much higher than in the general population (Brylewski & Wiggs, 1998; Brylewski & Wiggs,
1999; Stores, Stores, & Buckley, 1996; Wiggs & Stores, 1996). For example, Bartlett, Roney,
and Spedding (1985) conducted a study in which 80% of the parents of children with intellectual
disabilities reported one or more difficulties related to sleep. Didden et al. (2002) reported
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settling, night waking, and early waking as the most common of the severe problems reported in
children with intellectual disabilities. Quine (1991) also reported a high prevalence of sleep
problems with 51% of the sample having settling problems and 67% having problems with
waking during the night. Further, Stores et al. (1996) found that children with intellectual
disabilities were much more likely to have a sleep problem than typically developing children.
Thus, it is apparent that persons with intellectual disabilities appear to be particularly vulnerable
to sleep problems.
Most studies published concerning sleep problems in persons with intellectual disabilities
have been with children (Didden & Sigafoos, 2001; Espie & Tweedie, 1991). Quine (1991) and
Clements, Wing, and Dunn (1986) both found sleep disorders to be more common in children
under 5 than children over 5. The period of sleep problems experienced in the early development
of typically developing infants might apply to persons with intellectual disabilities. Indeed,
Bartlett et al. (1985) indicated that those children with intellectual disabilities in their study
appeared to be significantly slower at “growing-out” of sleep problems than were typically
developing children. Few studies have been published concerning the prevalence of sleep
problems in adults with intellectual disabilities. Brylewski and Wiggs (1999) evaluated 205
adults with intellectual disabilities for sleep problems. They reported the most frequent sleep
problem to be night waking, which occurred in approximately half of their sample.
A number of individuals with intellectual disabilities suffer from brain damage or
neuromaldevelopment. Neurological impairments such as severe locomotor disability, blindness,
and epilepsy were found to be predictors of sleep problems in persons with mental retardation
(Lindblom, Heiskala, Kaski, Leinonen, Nevanlinna, Iivanainen, & Laakso, 2001). Further,
damage to the structures that regulate REM sleep (pontine and forebrain), circadian rhythms
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(suprachiasmatic nucleus), and activation and arousal (ascending reticular formation) will likely
lead to disorders of these sleep systems. Indeed, REM sleep phase is one area in which
abnormalities may be found between persons with intellectual disabilities and the general
population (Grubar, 1983).
Breathing problems are an area that is of particular risk for persons with intellectual
disabilities. Problems related to breathing may result from any physical abnormality that
compromises an individual’s ability to breathe easily such as craniofacial abnormalities, scoliosis
of the spine, and disorder of the upper airway. Stores et al. (1996) found that children with
Down’s syndrome were particularly vulnerable to breathing related sleep problems. These
differences are most likely due to the physical differences found in Down’s syndrome,
particularly concerning craniofacial development.
In addition to physical abnormalities, the problem of discerning the etiology of sleep
problems is further complicated by the prevalence of medication use in this population. Lipman
(1970) found that psychotropic medications were taken by 51% of persons living in a residential
facility. A high prevalence of psychotropic use among persons with intellectual disabilities not
living in institutions has also been reported. Aman, Sarphare, and Burrow (1995) reported the
prevalence of receiving psychotropic medications to be 27% among persons with intellectual
disabilities living in community group homes. The most common psychotropics were
neuroleptics and anticonvulsants. Common side effects included sedation, daytime fatigue, REM
disturbance, and disturbed nocturnal sleep (Hoeppner, Garron, & Cartwright, 1984; Wetter,
Lauer, Gillich, & Pollmächer, 1996). Medication use may account for a number of the reports of
sleep problems among these individuals. However, no systematic studies evaluating the role of
psychotropic drug use on sleep problems in this population have been conducted.
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Another factor that requires consideration is that a large number of individuals with
intellectual disabilities suffer from seizure disorders. The abnormal brain activity associated with
seizures has the potential to alter a number of sleep systems. However, Espie and Tweedie
(1991) point out that this has been widely overlooked by researchers evaluating sleep disorders
in persons with intellectual disabilities. The frequent misdiagnosis of parasomnias as seizures
and vice-versa is further complicated in this population, who have a much higher incidence rate
of both seizure and sleep disorders (Deb & Joyce, 1999; Shepard, & Hosking, 1989; Steffenburg,
Hagberg, & Kylerman, 1996). The cyclical nature of sleep and seizure disorders only further
serves to increase the risk for persons with intellectual disabilities to develop sleep problems.
Persons with intellectual disabilities are a population warranting significant inquiry
concerning sleep problems. However, relative to the enormous body of research on sleep
disorders in the general population, these problems in persons with intellectual disabilities have
been overlooked. Of those studies that have been concerned with sleep problems in persons with
intellectual disabilities, most only looked at sleep in children. Indeed, the only measure
specifically designed to evaluate sleep problems in this population, the BEDS, is designed for
use with children (Schreck, 1997/1998).
Treatment of Sleep Disorders in Intellectual disabilities
The treatment of sleep disorders is highly specific to the particular symptom
manifestation. While there is a good deal of discussion concerning whether behavioral or
pharmacological treatments should be used as first line treatments, a recent meta-analysis by
Smith, Perlis, Park, Smith, Penington, Giles, and Buysse (2002) found both approaches to be
equally efficacious. Identifying specific environmental and behavioral variables may lead to
simple but effective treatments, without the risk of side-effects. However, Didden and Sigafoos
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(2001) point out the general lack of well-controlled treatment studies in persons with intellectual
disabilities. Nonetheless, there is a growing body of research available to suggest the efficacy of
a number of treatments (Lancioni, O’Reilly, & Basili, 1999).
Light therapy
Light therapy is a relatively easy and inexpensive method for treating sleep problems
such as insomnia or circadian rhythm disorder. Light therapy may consist simply of exposure to
bright natural or artificial light. Light therapy takes advantage of the strong role that light plays
as a zeitgeiber. Exposure to bright lights is a well-established treatment in the general population.
However, little has been done to explore the effectiveness of this treatment in persons with
intellectual disabilities. The available evidence does indicate though that light therapy may be
effective with this population. For example, Short and Carpenter (1998) report on the case of a
34 year-old with profound mental retardation that had problems with fragmented sleep and
daytime drowsiness. Following unsuccessful treatment attempts with sleep hygiene as well as
hypnotic medication, a regimen of exposure to direct sunlight for 2 hours each morning was
initiated. After two weeks of light therapy, his sleep stabilized and followed a normal pattern.
More recently, Altabet, Neumann, and Watson-Johnston (2002) presented three case studies in
which light therapy was effectively used to treat sleep problems. They also noted a decrease in
irritability as measured by the Aberant Behavior Checklist (Aman & Singh, 1985) and
depression as measured by the Diagnostic Assessment for Severe Handicaps (Matson, 1993).
Light therapy is a promising intervention for treating various sleep problems in persons with
intellectual disabilities. However, much still needs to be done to determine for which particular
sleep problems it is effective. Likewise, more controlled studies are needed before one can
accurately gauge its effectiveness.
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Chronotherapy
Chronotherapy was first developed as a treatment for delayed sleep phase syndrome.
Basically, each day the individual’s bedtime is pushed back by one to two hours. This is
continued until the appropriate bedtime is reach. In an evaluation of four congenitally blind
children with circadian sleep-wake rhythm disorder, Okawa and colleagues (1987) found that
chronotherapy was effective at entraining only one of the four children’s sleep cycles, with two
of the children’s sleep cycles responding to hypnotic medications following the failure of
chronotherapy. However, there is evidence showing improvement in sleep problems in persons
with intellectual disabilities when treated with chronotherapy. For example, Piazza, Hagopian,
Hughes, and Fisher (1998) report on the use of chronotherapy to effectively reduce sleep
problems in an 8 year-old girl with autism. Chronotherapy was originally designed based upon
the belief that the endogenous sleep-wake cycle in humans followed a 25-hour clock and that it
would be the easiest approach to resetting the person’s sleep time to the desired schedule.
However, later research has shown that the internal clock actually follows a cycle just over 24
hours (24.18), reducing the overall rationale for pushing the bedtimes later rather than earlier
(Stepanski & Perlis, 2003). Chronotherapy may be effective in some cases; however, considering
the overall efficacy of this approach, other less disruptive methods such as light therapy may be
preferred.
Sleep Hygiene
Sleep hygiene consists of day-to-day habits that either improve or degrade the quality and
amount of sleep for an individual. Many different sleep hygiene lists have been constructed for
research or clinical purposes, however, sleep hygiene lists do not vary dramatically and usually
consist of the same core items. These items include: getting up at the same time each day,
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keeping your bedroom free from light and noise, avoiding caffeine during the day and
particularly in the evening, and avoiding long daytime naps. Good sleep hygiene practices may
be of particular concern for persons living in residential care facilities, who often do not have
much influence over their daily routines or sleeping environments. Likewise, daytime napping is
often a frequent problem. While studies evaluating the use of sleep hygiene in persons with
intellectual disabilities as the sole treatment are virtually nonexistent, it has been used as a
component in a few studies. For example, Espie and Wilson (1993) report on the use of “optimal
scheduling” to improve sleep problems in 5 persons with intellectual disabilities. This procedure
was found to improve the overall sleep of the individuals in their study. However, results of their
study are limited by an AB design. In another study, Gunning and Espie (2003) found that by
using a combination of treatment components, which were individually tailored for each of their
12 participants, sleep problems were effectively treated. The treatment components used in their
study included optimal scheduling, sleep hygiene, stimulus control, relaxation, light therapy, and
cognitive behavioral therapy.
Sleep hygiene is a basic treatment for good sleep habits. It is usually considered an
adjunctive treatment though, requiring other more effective techniques to treat most sleep
problems (Smith, et al., 2003). Nonetheless, it is a necessary consideration when dealing with
persons with intellectual disabilities, who often do not have much personal control over these
decisions. By caretakers making sleep hygiene a factor when determining schedule and
environmental changes, the overall sleep quality for many of the individuals in their care may
improve.
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Faded Bedtime
Faded bedtime procedures have been found to be an effective intervention for bedtime
resistance and frequent night waking in children (Kuhn & Elliott, 2003). Fading usually consists
of altering the bedtime daily by 30 minutes based upon the child being able to fall asleep within
15 minutes. If the child does not fall asleep within 15 minutes, they are removed from bed and
kept awake for a period of an hour. This procedure has been found to be relatively effective in
reducing bedtime resistance and frequent night waking in persons with intellectual disabilities.
For instance, Piazza and Fisher (1991) evaluated the use of bedtime fading and response cost for
reducing sleep problems in 4 children with intellectual disabilities. Using a multiple-baseline
across-subjects design, they found that sleep disturbances were significantly reduced as well as
levels of appropriate sleep being improved. More recently, Piazza, Fisher and Sherer (1997)
compared the efficacy of faded bedtime with response cost to bedtime scheduling. They found
that sleep improved significantly more for the children in the faded bedtime with response cost
group than in the bedtime scheduling group.
Functional Analysis
Functional analysis is a useful tool to determine the environmental contingencies that
cause and maintain behavior. The functional analysis approach is dependent upon the assumption
that behavior is learned and maintained by environmental conditions. Much research has been
done that validates this assumption (Bachman, 1972; Carr, 1977; Iwata, Dorsey, Slifer, Bauman
& Richman, 1994), indicating that even maladaptive behaviors, such as self-injurious behavior
(SIB) may also be learned. While it is less likely that some sleep disorders such as BRSD are
operantly controlled, other sleep problems such as frequent night wakenings and disturbances are
readily affected by behavioral reinforcement (Didden, Curfs, van Driel, & de Moor, 2002).
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There is increasing evidence for the use of functional assessment in the treatment of sleep
problems in persons with intellectual disabilities. For example, Didden, Curfs, Sikkema, and de
Moor (1998) conducted functional assessments for 6 boys with intellectual disabilities. Results
of the functional analyses found that parent or caretaker attention maintained nighttime
disruptions for 4 of the boys, anxiety for 1 of the boys, and a combination of seizure activity and
attention for 1 boy. Extinction procedures were found effective at reducing nighttime disruptions
maintained by attention. For the child in whom nighttime disruptions were maintained by
anxiety, systematic desensitization was found effective. In a similar study, Didden et al. (2002)
conducted individual functional analyses for 3 children and 1 adult with intellectual disabilities
who were experiencing sleep problems. Using a multiple-baseline design, they found nighttime
disruptions that were maintained by attention to be successfully reduced by extinction. Further,
in a multiple-baseline design across subjects, Durand, Gernert-Dott, and Mapstone (1996) found
that a combination of graduated extinction and consistent bedtime routines were successful at
reducing nighttime wakenings and disturbances.
Considering the functional variables that may maintain sleep problems is a useful step in
devising effective treatments for sleep problems in persons with intellectual disabilities (Didden
et al., 2002). However, most studies found nighttime disruptions to be maintained by social
attention. While it is improbable that social attention maintains all occurrences of nighttime
disruptions, studies evaluating the prevalence of the various maintaining variables may be able to
identify particular variables that occur frequently, thus streamlining the assessment and treatment
process.
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Pharmacological Treatments
Pharmacological interventions are designed to primarily address one of two problems,
excessive daytime sleepiness or insomnia. First line treatment for excessive daytime sleepiness is
to target the underlying cause, which should be determined by a thorough evaluation. However,
when treatment of the underlying cause is unsuccessful or not possible, psychostimulants may be
a viable option. Psychostimulants that act on the sympathetic nervous system are termed
sympatheomimetic, and include amphetamine derivatives such as dexamphetamine and
methylphenidate. Historically the only non-sympatheomimetic psychostimulant popularly used
was caffeine, however, a relatively new psychostimulant, modafinil, falls into this class.
Methylphenidate is the most commonly prescribed psychostimulant (Challman & Lipsky, 2000),
however, it is likely that a large portion of prescriptions for methylphenidate are not to treat
daytime sleep disorders but other disorders such as Attention Deficit Hyperactivity Disorder.
While the specific mechanism of action for modafinil are unclear, it has a benign side effect
profile when compared to dexamphetamine and methylphenidate, which have a high abuse
potential (Jasinski, 2000). Recently, modafinil has received a considerable amount of attention
from researchers and is rapidly becoming the drug treatment of choice for excessive daytime
sleepiness (Banerjee, Vitiello, & Grunstein, 2004). However, no controlled studies of modafinil
in persons with intellectual disabilities have been conducted.
Most pharmacological treatments for sleep disorders have addressed insomnia. While
new agents are under development, all currently approved hypnotics act on the gamaaminobutyric acid (GABA)- benzodiazepine receptor complex and are still considered the drug
class of choice to treat insomnia (National Institute of Mental Health, 1984). In a survey of
psychiatrists and internist, Silberman (1998) found a generally negative view of using
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benziodiazepines for sleep problems. Likewise, prescription hypnotic use appears to be
decreasing (Mendelson, et al., 2004). In a 20-year review, Balter and Uhlenhuth (1991) report a
drop from 3.5 to 2.5% in persons who had been prescribed a hypnotic sleep agent. Further
evidence of the decline in hypnotic prescriptions can been seen in the 10-year review by
Schweitzer and Walsh (1998), who found a 20% decline in the use of hypnotic agents to treat
sleep problems.
While the use of hypnotic agents may be decreasing, there has been a dramatic increase
in off-label use of antidepressants and anxiolytics (Mendelson et al., 2004). Further, the
frequency with which over the counter medications are used to treat sleep problems should not
be underestimated. Johnson, Roehrs, Roth, and Breslau (1998) found that alcohol and over the
counter sleep aids were the most common methods used to treat sleep problems. Antihistamines
and alcohol are readily available for most adults and do not require the time or expense of a
doctor’s visit, which may account for their frequency of use over other sleep inducing agents.
Few researchers have examined the use of pharmacological treatments for sleep problems
in persons with intellectual disabilities. Despite the widespread use of these agents in persons
with intellectual disabilities and the high prevalence of sleep problems in this population, little
has been done to generalize the results found in general population studies to an understanding of
the effectiveness of pharmacological treatments for persons with intellectual disabilities. What
research exists appears to pertain almost exclusively to melatonin.
Melatonin is a well-established treatment for sleep problems in the general population
that has received increasing attention for use in persons with intellectual disabilities. Melatonin
administration has the opposite effect of exposure to bright light in that it advances the onset of
sleep when taken in the evening whereas light exposure pushes sleep onset back (Lack &
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Bootzin, 2003). There is some evidence suggesting the efficacy of melatonin administration in
persons with intellectual disabilities. Jan, Espezel, and Appleton (1993) reported on 15 case
studies in which melatonin treatment was found to significantly improve sleep. Likewise, Palm,
Blennow, and Wetterberg (1997) found that melatonin treatment was effective for treating
disturbed circadian sleep-wake rhythms in eight children. However, similar results have not been
found in more rigorous experimental designs. For instance, in a series of 6 double-blind singlesubject experiments, Camfield, Gordon, Dooley, and Camfield (1996) report a general lack of
response to melatonin. While some benefit was found as far as increasing overall sleep, the
amount of increase was not clinically significant enough for the families of the participants to
consider the long-term use of melatonin (Camfield et al., 1996). There is substantial evidence
from studies of melatonin administration in the general population to expect melatonin
administration to be effective in persons with intellectual disabilities. However, in light of the
finding by Camfied et al. (1996), it is clear that more rigorous experimental studies are needed.
Considering the overall effectiveness of pharmacological interventions to treat sleep
problems in the general population, it is unfortunate that so little has been done to evaluate its
use in persons with intellectual disabilities. This is particularly striking in light of the
comparatively high use of psychotropic medications in this population. One cannot simply
assume that these interventions will have the same effects in persons with intellectual disabilities
as has been found in the general population. More experimentally sound studies focusing on the
use of these treatments in persons with intellectual disabilities are needed.

35

RATIONALE
Sleep, a process often taken for granted, can disrupt many different areas of a person’s
day-to-day living if significant problems develop (Breslau et al., 1996; Ford & Kamerow, 1989).
Persons with intellectual disabilities frequently have a number of additional medical and
psychological conditions, occurring at a much greater rate than in the general population. Indeed
as discussed here, sleep disorders appear to occur at a much higher rate than in the general
population based on available evidence (Stores et al., 1996). However, since most of these
studies did not use measures designed for persons with intellectual disabilities, solid conclusions
are tentative despite the serious potential for poor quality of life for these persons. Indeed, using
scales that have been designed for use in the general population has multiple limitations when
applied to persons with intellectual disabilities (Favell, Realon, & Sutton, 1996; Green, Gardner,
& Reid, 1997). First, the format of most of these measures does not fit well. Almost all of the
questionnaires that have been designed to assess sleep disorders in the general population rely on
self-report. Many persons with intellectual disabilities are nonverbal and unable to report on
issues such as sleep quality or duration, and even for those persons with some verbal skills, the
likelihood of being able to comprehend the questions is highly unlikely. These issues are
particularly true for those in the severe and profound range of mental retardation. Further, of
those who are verbal, their verbal skills are usually poor and thus render any assessment based
solely on self-report as incomplete and in need of supplemental sources of information.
In response to these limitations, the SLEEPY was designed to be administered in an
indirect format, thus allowing the clinician to inquire about an individual’s sleep behavior
without the constraints of the individual’s ability to self-report. Further, the items on the
SLEEPY were developed after an extensive review of reported sleep problems in persons with
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developmental disabilities. Thus, the content of the SLEEPY is designed to specifically target
sleep problems as they appear in persons with developmental disabilities. While the BEDS
(Schreck, 1997) and the DASH-II (Matson, 1993) have been developed to assess for sleep
problems in this population, the BEDS was designed for the assessment of sleep problems in
children. Little is known concerning the developmental course of sleep problems across the
lifespan for individuals with developmental disabilities. It is likely that the type of sleep
problems will differ as the individual ages, as is seen in the general population. The DASH-II has
been developed to screen for psychopathology in adults. However, as is the nature of screening
instruments, the content is limited and designed to alert care-providers to areas that require
further inquiry. The SLEEPY was designed to serve as a systematic method to be used as that
second line of inquiry or as a stand-alone assessment for possible sleep problems.
Nonetheless, for such a scale to have utility, its reliability and validity need to be
established. The present study reports on the development of the SLEEPY and serves as an initial
effort to evaluate its reliability and validity. In particular, an item analysis was conducted to
remove any items with poor reliability or low endorsement. Secondly, the factor structure of the
remaining items was evaluated to develop subscales of the SLEEPY. Further, the test-retest and
inter-informant reliability of the subscales were evaluated. Finally, the validity of the SLEEPY
was evaluated in two ways. First, scores on the SLEEPY were compared to scores on the DASHII sleep subscale. Secondly, responses to SLEEPY items were compared to direct behavior
observations for a 24-hour period.
The development of a scale to reliably and validly assess sleep problems in this
population is of considerable importance. Such a scale has the potential to do much to improve
the quality of life for individuals with developmental disabilities who have suffered from sleep
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problems that have gone unnoticed. Further, research in the epidemiology and treatment of sleep
problems in persons with developmental disabilities has been hindered by the absence of
systematic means of assessment.
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METHOD
Participants
All participants were recruited from Pinecrest Developmental Center (PDC) in Pineville,
Louisiana. PDC is a residential developmental center that provides services for approximately
580 individuals with intellectual disabilities. Residents at PDC present with a variety of physical
and intellectual disabilities. Most of the individuals at PDC function in the range of severe and
profound mental retardation.
The SLEEp Problems InventorY (SLEEPY) is an indirect measure of sleep problems that
is designed to be administered in an interview format with a staff member who is familiar with
the day-to-day behavior of the individual. At PDC, each direct care staff member (group leader)
provides services for three to four individuals. Thus, the same person may serve as an informant
for up to four different individuals. Institutional Review Board approval for this project was
obtained through a previous proposal entitled: “Norming Psychological Assessment Battery for
Treatment Plans”.
A total of 400 participants were recruited. These individuals were randomly selected
from the overall population of residents at PDC. The sample of 400 participants consisted of 216
males and 184 females. Age ranged from 18 to 87 years (mean = 50.61 SD=13.36). Deafness
was present in 25 individuals (6.3%), blindness in 54 (13.5%), seizure disorder in 149 (37%),
226 were nonverbal (56.5%), and 136 were non-ambulatory (34%). The majority of the
participants functioned within the range of profound mental retardation (75%). Table 1 displays
the demographic information for the entire sample of 400 participants.
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Table 1
Demographic Characteristics of Participants
Demographic

Frequency

Percent of Sample

216
184

54
46

3
129
213
55

0.8
32.3
53.3
13.8

5
21
41
301
32

1.3
5.3
10.3
75.3
8

Gender
Male
Female
Age
0-21
22-45
46-65
66+
Level of Mental Retardation
Mild
Moderate
Severe
Profound
Unspecified

Inter-Informant Reliability
For a scale to have utility, staff and others familiar with the client must be able to
generally agree on which sleep items do and do not occur. In an effort to assess for error variance
due to differences among direct-care staff reports, 20% of the overall sample received
independent administrations of the SLEEPY by the same interviewer with an additional staff
member who had known the participant for at least 6 months and reported knowing well the
daily behavior of the participant. Because the SLEEPY is scored on an interval scale, the most
appropriate measure of inter-informant reliability is the Pearson product-moment correlation
(Haynes & O’Brien, 2000). Correlations were computed between raters in regards to severity as
well as for dichotomous scores (endorsement of the item occurring or not).
Participants were randomly selected from the overall participant pool of 400 individuals.
The demographics from the inter-informant sample reflect those of the overall study sample.
Demographic information for the inter-informant sample is shown in Table 2.
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Table 2
Demographic Characteristics of Participants in the Inter-Informant Sample
Demographic

Frequency

Percent of Sample

44
37

54.3
45.7

1
22
44
14

1.2
27.2
54.3
17.3

2
2
7
66
4

2.5
2.5
8.6
81.5
4.9

Gender
Male
Female
Age
0-21
22-45
46-65
66+
Level of Mental Retardation
Mild
Moderate
Severe
Profound
Unspecified

Test-Retest Reliability
In order to assess for error variance due to time sampling, 20% of the overall sample of
participants received a second administration by the same interviewer with the same informant
following a 1-2 week interval. The error variance between administrations may be influenced by
a number of factors including non-standardized administration, environmental changes, and
changes in the informant such as mood or level of arousal (Anastasi & Urbina, 1997). Regardless
of the source of variance, the more susceptible a measure is to changes in variables other than
that of the target construct, the less useful that measure becomes. Test-retest reliability was
computed between raters in regards to severity. The reliability coefficient is an index of
agreement between subsequent administrations of a measure by the same person (Anastasi &
Urbina, 1997). For the present study, the reliability coefficient was computed by the Pearson
product-moment method.
Participants for the test-retest sample were randomly selected from the overall participant
pool of 400 individuals. The demographics from the test-retest sample also reflect those of the
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overall population. However, subjects selected for the test-retest sample had slightly more males
than females, which is the opposite of the overall sample. Demographic information for the testretest sample is shown in Table 3.
Table 3
Demographic Characteristics of Participants in the Test-Retest Sample
Demographic

Frequency

Percent of Sample

35
45

43.8
56.3

0
24
40
16

0
30
50
20

1
7
9
57
6

1.3
8.8
11.3
71.3
7.5

Gender
Male
Female
Age
0-21
22-45
46-65
66+
Level of Mental Retardation
Mild
Moderate
Severe
Profound
Unspecified

Measures
Rating Scales
Over the past 10 years, rating scales have emerged as a viable means of assessing for
disorders or measuring skills in persons with intellectual disabilities (Matson & Bamburg, 1998;
Matson, LeBlanc, Weinheimer, & Cherry, 1999). Typically, they are administered in an
interview format with a person who is familiar with the individual such as a direct-care staff
member or a parent. Rating scales used in the present study included the SLEEPY and the
DASH-II.
SLEEPY
The SLEEPY is a measure designed to assess for symptoms of sleep disorders in persons
with developmental disabilities. The items on the SLEEPY were constructed by reviewing
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reports of particular symptoms of sleep disorders in persons with developmental disabilities in
published studies over the past 20 years. The SLEEPY was designed to be administered in an
interview format to a person who is familiar with the day-to-day behavior of the individual being
assessed. Items on the SLEEPY consist of statements about sleep-related behaviors of the
individual (i.e. “Will fall asleep if not otherwise occupied”). Each item of the SLEEPY is rated
on a three-point scale concerning the accuracy of the statement as well as the duration of the
behavior. The SLEEPY consists of both the questionnaire and a score sheet.
The SLEEPY is designed to serve two purposes. First, to act as a screening device that
alerts care providers to the possible presence of a sleep disorder, with the goal of leading to more
accurate referrals for the less efficient but more definitive procedures such as polysomnography.
The second goal of the SLEEPY is to provide areas for possible immediate intervention.
Diagnostic Assessment for the Severely Handicapped-II (DASH-II)
The DASH-II is an 84-item, informant-based screening tool designed to provide
information for the diagnosis of psychopathology for persons within the severe and profound
range of mental retardation. The scale is comprised of subscales representing 13 diagnostic
categories: (1) anxiety, (2) depression, (3) mania, (4) autism and other pervasive developmental
disorders, (5) schizophrenia, (6) stereotypies and tics, (7) self-injurious behavior (8) elimination
disorders, (9) eating disorders, (10) sleep disorders, (11) sexual disorders, (12) organic
syndromes, and (13) impulse control and other miscellaneous behaviors. All items are rated on
frequency, duration, and severity on a 0-2 Likert scale.
Behavior Observations
Sleep data was collected using momentary time-sampling (MTS) with 30-minute
intervals. Each participant was observed individually for a period of 2 minutes. The observations
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continued for a 24-hour period, resulting in 48 observations per participant. During the
observation period the observer recorded the behavior of the participant as well as various
environmental variables. Operational definitions for the target behaviors consisted of 1) sleeping:
defined as eyes closed, all movement or vocalizations appear sleep related; 2) snoring: defined as
audible breathing difficulties causing harsh snorting noises; 3) out of bed: not in bed for any
reason, regardless of sleep status; 4) in bathroom: defined as in bathroom regardless of activity or
sleep status; and 5) bruxism: defined as audible grinding or clicking noises while sleeping.
Environmental variables consisted of 1) temperature, as measure by a thermometer, 2) sound
level, as measured by a decibel meter; and 3) level of light, defined as dark, no light; dim, partial
light; or light, room lights on or in direct sunlight. These target behaviors and environmental
variables were selected to correspond to various items on the SLEEPY.
A second independent observer recorded data in order to compute the inter-informant
reliability of the behavior observations. For the inter-informant reliability observations, both
observers entered the room and observed the individual at the same time. Inter-informant
reliability data were collected on 20% of the sleep log participants. While a second observer was
available to collect reliability data for 100% of the sleep log sample, inter-informant
observations were limited to 20% in an effort to reduce any disturbance that the observations
may have caused to the participants. Agreement was defined as an interval in which both the
primary and secondary observer recorded the same occurrence of a behavior. Agreement
between observers were computed by dividing the number of agreements by the number of
agreements plus disagreements, then multiplying by 100 (Alberto & Troutman, 2003). Due to
unforeseen schedule changes among the participants in the sleep log sample, the two data
collectors for the daytime period were required to both serve as primary observers at different
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locations. Thus, calculations of the inter-informant reliability for the sleep log observations were
only available for the nighttime observations. Inter-informant reliability for the nighttime
observations was 100%.
Procedures
The SLEEPY was administered to direct-care staff by master’s-level clinicians.
Informants were selected based upon extensive experience with the participant (i.e., each
informant must have worked with the respective study participant for at least six months). In
most circumstances, the person who was the most qualified to serve as an informant was the
individual’s group leader. Further, the items on the SLEEPY are designed to measure sleep
problems that may occur throughout the entire 24-hour period. Because of the different times in
which sleep problems may occur, a single informant may not be able to report accurately
concerning behaviors that primarily occur when they are not present. For this reason, the initial
items on the SLEEPY were divided into two sections: Morning/Day and Evening/Night.
Informants responded to the items that corresponded to the time-period in which they primarily
cared for the participant. Items from the remaining time-period were completed by an additional
informant who primarily cared for the participant during that time-period. The SLEEPY is
administered in an interview (masters level psychologist), interviewee (direct care staff) format.
If the participant had been selected for the inter-informant reliability sample, an additional
SLEEPY was administered to another informant. If the participant had been selected for the testretest reliability sample, the same interviewer administered an additional SLEEPY to the same
informant following a 1-2 week interval.
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Factor Analysis
Factor analysis is commonly used in scale development as a means to construct
subscales. This procedure serves to simplify data by grouping together variables that are related
to one another. Factor analysis is a useful procedure for summarizing information obtained from
individual variables. While a useful tool, this procedure may not be appropriate or useful in all
situations, as discussed by Guilford (1952). There are a number of issues to bear in mind when
considering a factor analysis, among these are the minimum sample size needed, how many
factors to extract, and which extraction method is to be used.
For the present study, a total sample size of 400 was used. The SLEEPY consists of an
initial item pool of 72 items, many of which sample the same domain. While this ratio (5.5:1) is
sufficient to meet the minimum criteria set by a number of researchers (e.g. Gorsuch, 1983), the
expected factor correlations were unknown, and thus the stability of the factor solution may be
compromised. However, as the SLEEPY underwent an item analysis to remove unreliable or
unendorsed items prior to the factor analysis, the ratio of participants to items was much higher
than the 5:1 guideline.
For the exploratory factor analysis, the number of components to retain was determined
by computing a parallel analysis. Following the parallel analysis, an exploratory principal
components analysis was conducted, setting the number of factors to extract to that determined
by the parallel analysis. Items were assigned to the factor with the greatest loading. To be
included in a subscale, item loadings had to be above 0.4 (Gorsuch, 1983).
As the staff at PDC typically serve more than one individual at a time, it was expected
that the same person may have served as an informant for more than one questionnaire. It may be
argued that questionnaires using the same informant may not be sufficiently independent to
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appropriately run a factor analysis. A lack of independence poses the potential to introduce
systematic bias into the results of the analysis. Further, without examination, the stability of the
factor solution may not be assumed (Gorsuch, 1983). To evaluate for a lack of independence and
to evaluate the replicability of the factor structure found by the exploratory analysis, a second
exploratory analysis was conducted. For the second exploratory analysis, only one questionnaire
per informant was used. The second exploratory analyses included 201 completed
questionnaires.
Construct Validity
In establishing the validity of a measure, it is important to show that it both measures the
intended construct as well as not measuring unintended constructs. This is known as convergent
and discriminant validity (Anastasi & Urbina, 1997; Campbell & Fiske, 1959). The multi-trait
multi-method system as described by Campbell and Fiske (1959) is difficult to conduct
concerning a measure such as the SLEEPY. While an appropriate comparison measure, the
DASH-II, has been developed, the broad scope of this measure may limit comparisons to the
SLEEPY. Second, because of the widespread effect that sleep problems may have on the
functioning of an individual, a variety of domains may be related to elevations on the subscales
of the SLEEPY. Thus domains that traditionally conceptualized as unrelated such as autistic
behavior may indeed have sleep problems as significant predictors (Schreck, Mulick, & Smith,
2004). Further, as discussed earlier, sleep problems may significantly impact depression, anxiety,
and challenging behaviors (Brylewski & Wiggs, 1999; Didden et al., 2002). Because of this
widespread impact, it is difficult to suggest which domains should not be related to sleep
problems, indeed, to do so may be premature considering the available literature.
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To evaluate the validity of the SLEEPY, responses to the DASH-II sleep items were
compared to the corresponding SLEEPY items. Pearson product-moment correlations were
computed between the subscales and corresponding items on the SLEEPY with the DASH-II
sleep items.
In order to evaluate the predictive validity of the SLEEPY, responses to SLEEPY items
were compared directly to behavioral observations. Participants were classified into categories
for each relevant item of the SLEEPY. Scores of 0 were classified as “No”, 1 as “Maybe”, and 2
as “Yes”. These classifications were then compared to the corresponding data from the sleep log
observations. For the sleep log groups, participants were classified in regards to if they had been
observed engaging in the corresponding target behavior. Correct and incorrect classification rates
were then computed for each relevant item of the SLEEPY.
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RESULTS
Item Analysis
Each item on the SLEEPY was evaluated for overall variance of responses. Clark and
Watson (1995) recommend the elimination of items in which virtually all of the respondents
endorse or deny. In an overview of the development process of measures of this nature, Hagino
(2002) reports that the cut-off of 80 percent is commonly used. However, Clark and Watson
(1995) give the guideline of 95 percent. For the present study, any item that 90 percent or more
of the informants answered “no” to was removed from the final questionnaire prior to the factor
analysis. A total of 26 items were removed due to low endorsement. The items removed due to
low variance are listed in Table 4.
While item elimination due to low endorsement is important to streamline assessment and
reduce unstable correlations (Comrey, 1978), it is important not to eliminate construct-relevant
items even when endorsement is low (Clark & Watson, 1995). This is particularly the case when
the expected base-rate of the construct is low. Four items fell within this category in that they
met the 90 percent or more criteria for removal but were not removed due to clinical importance
and expected low base-rate of “yes” responses. These items include: 44. Has trouble breathing
while sleeping, 57. Stops breathing while sleeping, 65. Gags or chokes while sleeping, and 68.
Awakens during the night gasping for breath.
Table 4
Items Removed Due to Low Variance
SLEEPY Item

% “No”

3. Complains of headaches in the morning

97

24. Smokes cigarettes before going to bed

98

(Table 4 continued)
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30. Complains of loud noises during the night

97

31. Uses tobacco before going to bed

97

32. Complains of light disturbing sleep

98

33. Complains of others disturbing him/her while sleeping

95

34. Complains that the bedroom is too hot/cold

97

35. Eats a large snack before bed

91

41. Cries during the night

94

45. Sleeps in another’s bed

99

46. Does not want to sleep in his/her own bed

98

48. Sleepwalks

100

49. Talks while sleeping

98

52. Is afraid of noises at night

98

53. Is afraid to fall asleep

99

55. Requires medication to fall asleep

98

56. Sleeps poorly without medication

97

60. Rocks himself/herself to sleep

93

61. Awakens complaining of nightmares

99

62. Has a lengthy bedtime routine

95

64. Requires medication to sleep through the whole night

98

66. Has difficulty falling back to sleep when awoken during the night

91

69. Moves legs while sleeping

91

70. Moves arms while sleeping

92

71. Makes loud noises while sleeping

95

72. Has roommate who snores loudly

90

Item Test-Retest Reliability
Items were further evaluated for stability over time. Pearson product-moment correlation
coefficients were computed for each SLEEPY item between administrations for the test-retest
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sample. Items with coefficients below 0.5 were removed from the questionnaire before the factor
analysis. A total of 15 items were removed due to low correlation coefficients. The items
removed due to poor reliability are listed in Table 5.
Table 5
Items Removed due to Reliability Below 0.5
SLEEPY Item

r

9. Is sluggish when awoken

.428

12. Difficult to awaken in the morning

.390

20. Goes to bed earlier than his/her peers

.338

22. Sleeps more than 10 hours a day

.417

26. Drinks caffeinated beverages within 4 hours of bedtime

.350

38. Snores loudly

.349

39. Wakes up frequently during the night

.449

42. Has difficulty relaxing before bed

.457

43. Yells during the night

.398

47. Grinds teeth while sleeping

.248

51. Has difficulty relaxing at night

.435

54. Awakens during the middle of the night

.467

63. Awakens shortly after falling asleep

.372

65. Gags or chokes while sleeping

-.018

67. Does not keep a regular sleep schedule

.220

In reviewing the remaining items, it was noted that the majority of the items written to
address environmental factors that could cause or exacerbate sleep problems had been removed
during the previous two steps of item analysis. Thus, it was decided to remove the remaining
items designed to address environmental factors. In total, 5 items were removed for this reason.
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These items include: 6. The bedroom is brightly lit before he/she awakes, 21. Sleeps with nightlight, 27. Gets woken up by noise, 28. Bedroom is noisy while he/she is sleeping, 29. Sleeps with
room lights on. Following the item elimination, a total of 26 items remained.
Factor Analysis
To determine the number of components for the factor analysis, a parallel analysis was
conducted. However, this is not a standard analysis available in the most popular statistical
programs (SPSS & SAS). Fortunately, O’Connor (2000) provides the SPSS syntax necessary to
conduct this analysis. The syntax may also be downloaded from the following internet address:
http://flash.lakeheadu.ca/~boconno2/nfactors.html. Results of the parallel analysis indicated that
a 4-factor model was the most appropriate.
An exploratory factor analysis was conducted using SLEEPY item scores for the total
sample of 400 participants. A principal components analysis with varimax rotation and holding
the number of factors to 4 as determined by the parallel analysis (O’Connor, 2000) accounted for
43.8% of the observed variance. A secondary principal components analysis using promax
rotation found the same factor structure as the initial analysis that used varimax rotation,
indicating that the factors are likely orthogonal (Gorsuch, 1983).
Items were assigned to the factor with the greatest loading. However, item 19 was not
assigned to a factor due to an undifferentiated pattern of loading (Gorsuch, 1983). Likewise, item
40 was not assigned to a factor due to failure to meet the minimum loading of .4. Items 10, 15,
and 16 did not meet the minimum criteria of .4 to be assigned to a factor. However, as their
factor loading approached this level and met the commonly used but less stringent criteria for
factor loadings of .3 (e.g. Schreck, Mulick, & Rojahn, 2003) as well as considering that the item
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content matched the apparent theme of the factor, they were interpreted as meaningful to their
respective factor (Gorsuch, 1983). See table 6 for specific factor loadings.
From viewing table 6, it is evident that Items that loaded on the first factor primarily
consisted of daytime somnolence such as taking naps during the day, falling asleep at least once
during the day and appearing drowsy during the day. Thus, the first factor was titled “Daytime
Somnolence”. The second factor has the highest loadings with items concerning lack of sleep,
nighttime wakening, arising extremely early in the morning, and getting out of bed during the
night. Thus, factor two was titled “Sleep Maintenance”. Items loading on the third factor
consisted of problems with waking-up and sleeping longer then others. Thus the third factor was
titled “Hypersomnia”. Items loading on the fourth factor were concerned exclusively with
breathing related sleep problems, thus this factor was titled “Breathing Related Sleep Problems”.
Table 6
Factor Loadings and Percent Variance for Exploratory Analysis
Factor 1: Daytime Somnolence (17.5%)
Item #
Item
1
Takes naps during the day
2
Falls asleep when bored
4
Will fall asleep if not otherwise occupied
7
Appears sleepy during the day
8
Falls asleep at least once during the day
14
Appears drowsy during the day
15
Is inactive during the day

Factor Loading
.757
.798
.741
.686
.824
.644
.388

Factor 2: Sleep Maintenance (11.9%)
Item #
Item
17
Awakens extremely early in the morning
18
Gets out of bed early
23
Sleeps less than 6 hours a day
25
Is very active before bedtime
36
Wakes up frequently to go to the bathroom
37
Drinks fluids before going to sleep
50
Disrupts other’s sleep
58
Repeatedly gets out of bed
59
Refuses to go to bed

Factor Loading
.681
.738
.479
.452
.364
.393
.519
.702
.579

(Table 6 continued)
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Factor 3: Hypersomnia (7.7%)
Item #
Item
5
Gets out of bed later than his/her peers
10
Is disoriented (confused) when awoken
11
Wakes up looking tired
13
Sleeps longer than most of his/her peers
16
Is irritable during the day

Factor Loading
.671
.437
.557
.701
.361

Factor 4: Breathing Related Sleep Problems (6.8%)
Item #
Item
44
Has trouble breathing while asleep
57
Stops breathing during sleep
68
Awakes during the night gasping for breath

Factor Loading
.738
.867
.819

In an effort to evaluate the stability of the factor structure, a second exploratory analysis
was conducted. For this analysis, one questionnaire was randomly selected from each informant,
such that, only one questionnaire per informant was used. The total number of participants for
this analysis was 201. Table 7 presents the factor loadings.
Table 7
Factor Loadings and Percent Variance for Second Exploratory Analysis
Factor 1: Daytime Somnolence (17.3%)
Item #
Item
1
Takes naps during the day
2
Falls asleep when bored
4
Will fall asleep if not otherwise occupied
7
Appears sleepy during the day
8
Falls asleep at least once during the day
10
Is disoriented (confused) when awoken
14
Appears drowsy during the day

Factor Loading
.760
.781
.732
.632
.838
.416
.630

Factor 2: Sleep Maintenance (11.8%)
Item #
Item
17
Awakens extremely early in the morning
18
Gets out of bed early
23
Sleeps less than 6 hours a day
25
Is very active before bedtime
36
Wakes up frequently to go to the bathroom
37
Drinks fluids before going to sleep
50
Disrupts other’s sleep
58
Repeatedly gets out of bed
59
Refuses to go to bed

Factor Loading
.677
.750
.528
.429
.392
.363
.438
.698
.504

(Table 7 continued)
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Factor 3: Breathing Related Sleep Problems (6.2%)
Item #
Item
44
Has trouble breathing while asleep
57
Stops breathing during sleep
68
Awakes during the night gasping for breath

Factor Loading
.763
.896
.829

Factor 4: Hypersomnia (8.2%)
Item #
Item
5
Gets out of bed later than his/her peers
13
Sleeps longer than most of his/her peers
15
Is inactive during the day
16
Is irritable during the day

Factor Loading
.707
.760
.435
.380

Subscale Inter-Rater Reliability
20 percent of the overall sample of participants were selected to receive a second
administration of the SLEEPY using a different staff member as the informant. Pearson productmoment correlations were conducted among SLEEPY subscale and total scores for each
administration. Overall, correlations between informants were moderate. Due to a lack of
variance on the BRSP subscale among the participants chosen for the inter-rater sample, a
reliability coefficient was unable to be computed. Results of subscale correlations between
informants are presented in table 8.
Table 8
SLEEPY Subscale Inter-Rater Reliability Correlation Coefficients
Subscale
Factor 1:Daytime Somnolence
Factor2: Sleep Maintenance
Factor 3: Hypersomnia
Factor 4: BRSP
Total Score

r
.568
.527
.729
NA
.725

p-value
<0.000
<0.000
<0.000
NA
<0.000

Subscale Test-Retest Reliability
To assess for consistency of informant responses to SLEEPY items over time, 20% of the
overall sample received a second administration of the SLEEPY with the same informant
following a one to two week interval. Pearson product-moment correlations were computed for
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each subscale and the total score between each administration. Correlations were again moderate.
Results of subscale and total score correlations between administrations are presented in table 9
Table 9
SLEEPY Subscale Test-Retest Reliability Correlation Coefficients.
Subscale
Factor 1:Daytime Somnolence
Factor2: Sleep Maintenance
Factor 3: Hypersomnia
Factor 4: BRSP
Total Score

r
.744
.636
.731
.779
.732

p-value
<0.000
<0.000
<0.000
<0.000
<0.000

Validity
To evaluate the validity of the SLEEPY, Pearson product moment correlations were
computed between the subscales of the SLEEPY and the sleep scale items of the DASH-II.
Further, the SLEEPY total score was correlated with the DASH-II sleep scale items. Due to lack
of variance among responses to the DASH-II item “sleepwalks”, the correlation coefficient was
not computed. Results of item correlations between DASH-II sleep scale items and SLEEPY
subscales are presented in table 10.
Table 10
Pearson Product Moment Correlation Coefficients for DASH-II Items and corresponding
SLEEPY Subscales.
DASH-II Item
14. Has difficulty staying awake
during the day.
19. Wakes up frequently during the
night.
39. Has difficulty getting to sleep.
79. Wakes up crying or screaming.
14. Has difficulty staying awake
during the day.
19. Wakes up frequently during the
night.
39. Has difficulty getting to sleep.
79. Wakes up crying or screaming.

SLEEPY Subscale
Daytime Somnolence

r
0.574

p-value
<0.000

Sleep Maintenance

.414

<0.000

Sleep Maintenance
Sleep Maintenance
Total Score

.268
.181
.475

<0.000
<0.000
<0.000

Total Score

.372

<0.000

Total Score
Total Score

.140
.186

<0.000
<0.000
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In order to evaluate the predictive validity of the SLEEPY, responses to SLEEPY items
were compared directly to behavioral observations. Table 11 presents the classification of
individual SLEEPY items compared to behavioral observations. Results are reported in regards
to the number and percent of participants classified by each method.
Table 11
Classification rates for SLEEPY items Compared to Behavioral Observation
SLEEPY Item 1
Takes naps during the day

SLEEPY Item 2
Falls asleep when bored

SLEEPY Item 4
Will fall asleep if not otherwise occupied

SLEEPY Item 5
Gets out of bed later than his/her peers

SLEEPY Item 8
Falls asleep at least once during the day

SLEEPY Item 17
Awakens extremely early in the morning

No
Yes
Maybe

Observed asleep during the day
No
Yes
11 (61%)
1 (9%)
2 (11%)
5 (45%)
5 (28%)
5 (45%)

No
Yes
Maybe

Observed asleep during the day
No
Yes
10 (56%)
6 (54%)
1 (6%)
5 (45%)
7 (39%)
0 (0%)

No
Yes
Maybe

Observed asleep during the day
No
Yes
11 (61%)
4 (36%)
1 (6%)
5 (45%)
6 (33%)
2 (18%)

No
Yes
Maybe

Out of bed after wake-up
No
Yes
25 (96%)
2 (67%)
1 (4%)
0 (0%)
0 (0%)
1 (33%)

No
Yes
Maybe

Observed asleep during the day
No
Yes
7 (39%)
3 (27%)
4 (22%)
6 (55%)
7 (39%)
2 (18%)

No
Yes
Maybe

Out of bed before wake-up
No
Yes
17 (71%)
5 (100%)
0 (0%)
0 (0%)
7 (29%)
0 (0%)

(Table 11 continued)
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SLEEPY Item 18
Gets out of bed early

SLEEPY Item 23
Sleeps less than 6 hours a day

SLEEPY Item 44
Has trouble breathing while asleep

SLEEPY Item 58
Repeatedly gets out of bed

No
Yes
Maybe

Out of bed before wake-up
No
Yes
17 (71%)
5 (100%)
1 (4%)
0 (0%)
6 (25%)
0 (0%)

No
Yes
Maybe

Less than 6 hours of sleep
No
Yes
23 (88%)
2 (67%)
0 (0%)
0 (0%)
3 (12%)
1 (33%)

No
Yes
Maybe

Snored during the observation
No
Yes
16 (89%)
11 (100%)
1 (6%)
0 (0%)
1 (6%)
0 (0%)

No
Yes
Maybe

Observed out of bed during night
No
Yes
15 (75%)
5 (56%)
1 (5%)
1 (11%)
4 (20%)
3 (33%)
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DISCUSSION
A major limitation in understanding sleep problems in persons with developmental
disabilities is the relative lack of reliable and valid assessment tools (Didden & Sigafoos, 2001;
Johnson, 1996). The present study was an initial effort to develop a tool for the identification of
sleep problems in persons with developmental disabilities. As a part of this process, the
psychometric properties of the SLEEPY were examined. In particular, the factor structure, interrater reliability, test-retest reliability, and construct validity of the SLEEPY were evaluated.
Based upon the results of these analyses, the following conclusions are available.
Factor Structure
An exploratory factor analysis of the SLEEPY using varimax rotation yielded a 4-factor
solution. Twenty-four items were grouped into the following factors (1) Daytime Somnolence,
(2) Sleep Maintenance, (3) Hypersomnia, and (4) Breathing Related Sleep Problems. These
factors address four primary areas in which sleep problems may occur. The purpose in
developing this instrument was to provide a means to rapidly assess individuals with
developmental disabilities for sleep problems. By providing information concerning these
specific domains in which sleep problems may occur, the SLEEPY may meet this purpose and
allow clinicians to more quickly determine the area in which to invest more robust but costly
assessment methods.
A second exploratory factor analysis was conducted using only one questionnaire per
informant to evaluate the stability of the factor structure. Overall, the factors showed good
stability. However, three items changed in their factor loadings. Item 10, which was originally
assigned to the Hypersomnia subscale, loaded higher on the Daytime Somnolence subscale.
Likewise, item 15, which loaded highest on the Daytime Somnolence subscale for the
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exploratory analysis loaded highest on the Hypersomnia subscale on the second exploratory
analysis. Further, item 11, which was assigned to the Hypersomnia subscale by the exploratory
analysis loaded on too many factors to warrant assignment to any particular factor found by the
second exploratory analysis.
While the overall factor structure of the SLEEPY did not significantly change between
analyses, the instability of these three items is cause for some concern. It is noteworthy that items
10 and 15 did not meet the criteria of factor loadings above .4 but were retained due to apparent
homogeneity with the theme of the factor and because they met the less stringent criteria of
similar measures (Schreck et al., 2003). The decision to retain these items may have been an
error. However, the instability of the factor loadings for these three items may have been a result
of an insufficient sample size for the second exploratory principal components analysis
(DeVellis, 1991). Future confirmatory principal component analyses on independent
administrations of the SLEEPY should help to clarify this issue.
Reliability
Inter-rater reliability coefficients for the SLEEPY total score and subscales fell within the
moderate range. While reliability coefficients were not as robust as one might hope, results
suggest that informants may reliably report on the day-to-day sleep behavior of the participants
for the total score and the Hypersomnia subscale. The Daytime Somnolence and Sleep
Maintenance scales showed moderate inter-rater reliability. From these data, it is evident that the
person chosen to serve as an informant on the SLEEPY may significantly impact an individual’s
Daytime Somnolence and Sleep Maintenance scores. As the individuals who live at PDC are
primarily cared for by one person per shift, the secondary informant was most likely less
informed about the participant’s day-to-day behavior than the primary care provider. While

60

criteria were in place to control for the reduced familiarity of the secondary informants with the
participant, the assumption that another informant whose duties focus on other individuals would
be familiar enough to serve as a knowledgeable informant may have been wrong. Regardless of
the source of error, the Daytime Somnolence and Sleep Maintenance subscales should be
interpreted cautiously and care should be used to insure that informants are adequately familiar
with the individual’s day-to-day behavior.
Test-retest reliability coefficients also fell in the moderate range, suggesting that while
they may be susceptible to some variation across a one to two week period, informant responses
are fairly stable over time. It is questionable if the difference observed between administrations
is true variance or not. While it is presumed that sleep problems will be fairly stable across a
two-week period, the lack of studies evaluating sleep problems in persons with developmental
disabilities obscures our knowledge of what the true variance is. Thus, it is difficult to discern if
the moderate correlations are a threat to the ability of the SLEEPY to reliably measure sleep
problems over time. Further research is needed to clarify this issue. In particular, future studies
using direct behavior observations across a number of weeks would help to clarify the issue of
whether or not sleep problems are stable within this population.
Validity
The DASH-II sleep subscale consists of items that are worded and administered in the
same manner as SLEEPY items. Most of the correlation coefficients, while statistically
significant, were in the low range. It may be the case that for some items, the questions were
phrased in such a way that the informant might have perceived them differently (i.e. DASH-II
item 14. “Has difficulty staying awake during the day” and SLEEPY item 4.” Will fall asleep if
not otherwise occupied”). Another explanation for this relatively low correlation coefficient may
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be the period of time that is queried by the different measures. For items on the SLEEPY, the
informant is instructed to consider the past month and then is asked to rate how accurate the
statement is. Whereas the DASH-II instructs informants to consider the past two-weeks and to
rate how frequently the behavior has occurred. The different criteria will result in the DASH-II
having a smaller window in which the sleep problem may have occurred. Further, the DASH-II
instructs informants to report the frequency of the behavior. In contrast, the SLEEPY items ask
the informant to respond concerning the accuracy of the statement. These two methods differ
significantly. One method relies upon recall of behavior while the other relies upon the
informants overall perception of behavior. Informants responding to the DASH-II items reported
fewer sleep problems than they did on the SLEEPY items. The lower rate of endorsement on the
DASH-II may be due to informants’ inability to recall specific occurrences or apprehension of
over endorsement.
Classification decisions using SLEEPY item scores were compared to classifications
made using direct observations over a period of 24 hours. The classification rates of the SLEEPY
can be interpreted in regards to type 1 and type 2 errors, that is, rejecting the null hypothesis
when it is true (type 1) and retaining the null hypothesis when it is false (type 2). Overall, the
SLEEPY showed very low rates of false positives. However, the occurrence of false negatives
was much higher. Thus, individual SLEEPY items showed good specificity when compared to
behavioral observations but questionable sensitivity.
Regarding specific behavioral observations, the sleep log data “observed asleep during
the day” corresponded to the following SLEEPY items: 1. takes naps during the day, 2. Falls
asleep when bored, and 4. Will fall asleep if not otherwise occupied. The most generally worded
of these items, number 1, showed the highest sensitivity, falsely rejecting only 9% of those
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individuals who were observed sleeping during the day. However, the more specifically worded,
items of 2, 4, and 8, showed poorer sensitivity, falsely rejecting 54, 36, and 27% of those
individual’s who were observed sleeping during the day. It is likely that staff are unsure of the
particular cause for napping during the day such as boredom or lack of activities and thus are
reluctant to answer in the affirmative to specific causes.
Concerning the observation of “not out of bed after wake-up”, three individuals were
observed to not be out of bed. Of these three participants, item 5 misclassified two as not having
problems with getting out of bed later than their peers. Similar to the observation “not out of bed
after wake-up” the behavior observation “out of bed before wake-up” showed poor
correspondence with SLEEPY items 17 and 18. Five participants were observed to get out of bed
before the morning staff woke-up their peers. Of these five, items 17 and 18 misclassified 100%
as not having problems with awakening early in the morning and getting out of bed early. One
explanation for this poor sensitivity is that daytime staff may not arrive early enough to answer
these items accurately. Awaking and helping the residents to get ready in the morning are among
the final duties of the night staff at PDC. Thus, the daytime staff should not be informants for
items 17 and 18.
The SLEEPY item 44 “has trouble breathing while sleeping” showed poor sensitivity
when compared to the number of participants who were observed snoring during the behavior
observations. Eleven participants were observed snoring for at least one interval throughout the
24-hour observation. Informants responded “no” on item 44 for all eleven of these participants. It
may be the case that the informants did not consider snoring as troubled breathing. Considering
that item 38 “snores loudly” was removed due to poor reliability, it is questionable if phrasing
item 44 to more specifically match the observation of snoring would improve the sensitivity.
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Further, Hoffstein and Szalai (1993) reported that clinicians who commonly see patients with
sleep problems showed poor sensitivity to breathing related sleep problems. Thus, it should not
be surprising informants in the current study, who were not trained in the diagnosis of sleep
problems, also showed poor sensitivity.
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CONCLUSION
The SLEEPY was designed as a measure to efficiently assess for sleep problems in
persons with developmental disabilities. This initial effort presents data on the factor structure,
reliability, and validity of the SLEEPY. The factor structure of the SLEEPY resulted in four
domains of sleep problems. The same factors were found by a second exploratory principal
components analysis. While three items changed in regards to their factor loadings, the overall
factor structure of the SLEEPY appeared stable. Adequate inter-rater reliability was shown for
the Hypersomnia and BRSP subscales of the SLEEPY. Likewise, the total score showed
adequate inter-rater reliability, indicating that informants generally agreed on the overall level of
sleep problems in participants. However, the Daytime Somnolence and Sleep Maintenance
subscales showed questionable reliability. Thus, care should be used in selecting appropriate
informants. To meet this need, future research should evaluate which characteristics are
important when considering what constitutes a qualified informant.
Adequate test-retest reliability was found for all of the subscales and the total score of the
SLEEPY. Thus, they showed adequate stability for their ratings of sleep problems over time.
Multiple-week objective monitoring (such as behavior observations, actigraphy or PSG) of sleep
problems should help elucidate the true variability of sleep problems among persons with
developmental disabilities. Future test-retest reliability evaluations should be interpreted in light
of any new findings.
Evaluation of the validity of the SLEEPY showed mixed results. Comparisons to direct
behavioral observations found SLEEPY items to have excellent specificity but low sensitivity to
sleep problems. It is worth noting that the informants under-reported sleep problems rather than
over-reported. The low sensitivity of the SLEEPY may reflect the degree to which direct care
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staff were aware of the less overt sleep behaviors of the participants. Behaviors of long duration
such as daytime napping showed better classification rates than other behaviors such as snoring,
which may occur covertly and only be notice by direct care staff if they happen to check-in on
the individual at that point in time. Indeed, in a study on the relationships between sleep
organization, sleep disorders and epilepsy, Bruni, Cortesi, Giannotti, and Curatolo (1995) found
that parents missed a high number of brief awakenings relative to PSG.
While the present study found low sensitivity for the SLEEPY to detect sleep problems as
measured by behavior observations, results are similar to those reported by Espie et al. (1998)
who compared caregiver reports of sleep in sleep-diaries to EEG. Espie et al. (1998) found
caregiver report to over-estimate sleep length by approximately 1 hour. Further, the only
caregiver variable that predicted the participants’ as appearing “refreshed” upon awakening was
an early bedtime, not the number of nighttime awakenings or sleep latency. Thus in both the
present study and the results reported by Espie et al. (1998) and Bruni et al. (1995), caregiver
report was found to under-report sleep problems but to be significantly related to objective
measures of sleep.
The present results concerning informant-report of sleep problems are interesting when
compared to findings concerning self-reported sleep problems. Self-reported sleep diaries
typically overestimate sleep problems in relation to objective measures of sleep (Tyron, 2004).
When using caregivers to report on sleep problems, the opposite trend occurs and sleep problems
are underreported relative to objective measures (Espie et al., 1998). It is likely that the low
sensitivity of the SLEEPY when compared to behavior observations is due to the caregiver’s
tendency to underestimate sleep problems. Perhaps with caregiver training to attend to more
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sleep related variables as well as coaching to lower the informant’s threshold for what constitutes
problem sleep may increase the sensitivity of the SLEEPY.
Informant based questionnaires offer rapid and less costly means to assess for sleep
problems in persons with developmental disabilities. However, indirect assessments are often
less valid than direct observations (Johnston & Pennypacker, 1993). The utility of informant
based questionnaires is dependent upon the reliability of the informants used to answer items
(Smith, et al., 2003). The present study assessed the psychometric properties of the SLEEPY
using participants from a large developmental center in Louisiana. Further research is needed to
evaluate the psychometric properties of the SLEEPY using different informant populations. For
example, it is likely that parents who live with their child with developmental disabilities would
have a much better understanding of their child’s daily behavior, particularly in light of their
exposure to their child on a 24-hour basis.
On the whole, these data are promising. The results of the present study indicate that
further studies evaluating the reliability and validity of the SLEEPY are warranted. The most
significant limitation of the SLEEPY appears to center on the degree to which informants may
reliably and accurately report on various sleep problems. This issue should be the primary focus
of future research.
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